| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Revenue | $12.26B | -3.2% |
| Cost of Revenue | $10.01B | -3.4% |
| R&D Expense | $72.0M | -12.2% |
| SG&A Expense | $892.0M | +0.7% |
| Operating Income | $937.0M | -13.2% |
| Pre-tax Income | $611.0M | -17.7% |
| Income Tax | $95.0M | -28.6% |
| Net Income | $516.0M | -15.3% |
| EPS (Basic) | $4.48 | -11.6% |
| EPS (Diluted) | $4.38 | -11.5% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.09B | -9.0% |
| Accounts Receivable | $1.60B | +2.3% |
| Inventory | $1.63B | +4.8% |
| Current Assets | $4.57B | +0.9% |
| Total Assets | $16.61B | +0.2% |
| Current Liabilities | $3.67B | +35.3% |
| Long-term Debt | $7.50B | -16.3% |
| Line Item | 2024-09-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.41B | -13.0% |
| Capital Expenditures | $551.0M | -20.0% |
| Investing Cash Flow | -$572.0M | +26.3% |
| Financing Cash Flow | -$966.0M | +9.8% |
| Free Cash Flow | $854.0M | -7.8% |
| Total Liabilities |
| $13.01B |
| -2.7% |
| Stockholders' Equity | $3.61B | +12.2% |